Related Experiment Video
Updated: Jan 17, 2026
Label-Free Quantitative Proteomics Workflow for Discovery-Driven Host-Pathogen Interactions
Published on: October 20, 2020
Insights from Mass Spectrometry-Based Proteomics on Cryptococcus neoformans
Jovany Jordan Betancourt1, Kirsten Nielsen1,2
1Department of Microbiology and Immunology, University of Minnesota, Minneapolis, MN 55455, USA.
Abstract:
Cryptococcus neoformans is an opportunistic fungal pathogen and causative agent of cryptococcosis and cryptococcal meningitis (CM). Cryptococcal disease accounts for up to 19% of AIDS-related mortalities globally, warranting its label as a pathogen of critical priority by the World Health Organization. Standard treatments for CM rely heavily on high doses of antifungal agents for long periods of time, contributing to the growing issue of antifungal resistance. Moreover, mortality rates for CM are still incredibly high (13-78%). Attempts to create new and effective treatments have been slow due to the complex and diverse set of immune-evasive and survival-enhancing virulence factors that C. neoformans employs. To bolster the development of better clinical tools, deeper study into host-Cryptococcus proteomes is needed to identify clinically relevant proteins, pathways, antigens, and beneficial host response mechanisms. Mass spectrometry-based proteomics approaches serve as invaluable tools for investigating these complex questions. Here, we discuss some of the insights into cryptococcal disease and biology learned using proteomics, including target proteins and pathways regulating Cryptococcus virulence factors, metabolism, and host defense responses. By utilizing proteomics to probe deeper into these protein interaction networks, new clinical tools for detecting, diagnosing, and treating C. neoformans can be developed.
Insights
Proteomics reveals insights into Cryptococcus neoformans virulence and host responses, aiding the development of new diagnostics and treatments for cryptococcal meningitis (CM). This research addresses critical needs for effective antifungal strategies against this opportunistic pathogen.
Area of Science:
- * Medical Mycology
- * Infectious Diseases
- * Proteomics
Background:
- * Cryptococcus neoformans is a critical opportunistic fungal pathogen causing cryptococcosis and cryptococcal meningitis (CM).
- * CM is a leading cause of mortality in AIDS patients, with high mortality rates (13-78%) and growing antifungal resistance.
- * Current treatments are limited by long-term high-dose antifungals and C. neoformans' complex virulence factors.
Purpose of the Study:
- * To explore host-Cryptococcus proteomes using mass spectrometry-based proteomics.
- * To identify clinically relevant proteins, pathways, and antigens for improved diagnostics and therapeutics.
- * To understand host defense mechanisms against C. neoformans.
Main Methods:
- * Mass spectrometry-based proteomics was employed to analyze host-pathogen interactions.
- * Proteomic data was used to investigate C. neoformans virulence factors, metabolism, and host responses.
Main Results:
- * Proteomics provided insights into C. neoformans biology and cryptococcal disease mechanisms.
- * Identified target proteins and pathways involved in fungal virulence and host defense.
Conclusions:
- * Proteomics is invaluable for understanding complex host-pathogen interactions in cryptococcosis.
- * Further proteomic studies can facilitate the development of novel clinical tools for detecting, diagnosing, and treating C. neoformans infections.
- * This approach aids in overcoming challenges posed by antifungal resistance and high CM mortality.
Related Concept Videos
01:19MALDI-TOF Mass Spectrometry
01:33Proteomics
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...